Suchergebnisse - "Munakata, W"

PubPharm (15)

1

Tirabrutinib hydrochloride for B-cell lymphomas

enthalten in: Drugs of today (Barcelona, Spain : 1998) | 2021

von Munakata, W. | Tobinai, K.

2

Tirabrutinib hydrochloride for B-cell lymphomas

enthalten in: Drugs of today | 2021

von Munakata, W. | Tobinai, K.

3

THE ROLE OF SURVEILLANCE COMPUTED TOMOGRAPHY IN PATIENTS WITH FOLLICULAR LYMPHOMA

enthalten in: Hematological Oncology | 2019

von Hatta, S. | Fukuhara, S. | Fujino, T. | +7

4

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma

enthalten in: Blood cancer journal | 2017

von Saito, H. | Maruyama, D. | Maeshima, A. | +9

ErratumFor: Blood Cancer J. 2015 Oct 23;5:e362. - PMID 26495859

5

LONG‐TERM FOLLOW‐UP AFTER LOCALIZED RADIOTHERAPY IN PATIENTS WITH TRANSFORMED B‐CELL LYMPHOMA TREATED WITH RITUXIMAB‐CONTAINING CHEMOTHERAPY

enthalten in: Hematological oncology | 2017

von Nozaki, K. | Maruyama, D. | Tajima, K. | +13

6

ONO‐4059 (GS‐4059), A NEXT GENERATION BTK INHIBITOR, MONOTHERAPY IN PATIENTS WITH B‐CELL MALIGNANCIES IN THE JAPANESE PHASE 1, DOSE‐ESCALATION STUDY

enthalten in: Hematological oncology | 2017

von Ando, K. | Hatake, K. | Fukuhara, N. | +8

7

ASSESSMENT INDEX OF CLINICAL TRANSFORMATION FROM FOLLICULAR LYMPHOMA (FL) TO DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA

enthalten in: Hematological oncology | 2017

von Shichijo, T. | Maruyama, D. | Tajima, K. | +11

8

Fertility and social reintegration after modified CODOX‐M/IVAC with or without rituximab: A questionnaire survey of non‐Hodgkin lymphoma

enthalten in: Hematological oncology | 2017

von Toyoda, K. | Maruyama, D. | Kurosawa, S. | +10

9

Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era

enthalten in: Blood cancer journal | 2016

von Kawajiri, A. | Maruyama, D. | Maeshima, A. | +12

10

Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma

enthalten in: Blood cancer journal | 2015

von Saito, H. | Maruyama, D. | Maeshima, A. | +9

ErratumIn: Blood Cancer J. 2017 Nov 3;7(11):e620. - PMID 29099480